Receptor oligomerization in family B1 of G-protein-coupled receptors: Focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity

Frontiers in Endocrinology

Volumn 3, Issue MAY, 2012, Pages

  Roed, Sarah Norklit ^a   Orgaard, Anne ^b   Jorgensen, Rasmus ^a   De Meyts, Pierre ^c  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

Binding cooperativity; BRET; Family B1; GPCRs; Oligomerization

Indexed keywords

EID: 84871353890     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00062     Document Type: Review

References (98)

1. AbdAlla, S., Lother, H., el, M. A., and Quitterer, U. (2001). Increased AT(1) receptor het-erodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7, 1003-1009.
2. Albizu, L., Cottet, M., Kralikova, M., Stoev, S., Seyer, R., Brabet, I., Roux, T., Bazin, H., Bourrier, E., Lamar-que, L., Breton, C., Rives, M. L., Newman, A., Javitch, J., Trinquet, E., Manning, M., Pin, J. P., Mouil-lac, B., and Durroux, T. (2010). Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat. Chem. Biol. 6, 587-594.
3. Ali, S., and Drucker, D. J. (2009). Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 296, E415-E421.
4. Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., and Bouvier, M. (2000). Detection of beta 2-adrenergic receptor dimer-ization in living cells using biolumi-nescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. U.S.A. 97, 3684-3689.
5. Authier, F., and Desbuquois, B. (2008). Glucagon receptors. Cell. Mol. Life Sci. 65, 1880-1899.
6. Ayoub, M. A., and Pfleger, K. D. (2010). Recent advances in bioluminescenceresonance energy transfer technologies to study GPCR heteromeriza-tion. Curr. Opin. Pharmacol. 10, 44-52.
7. Bagger, J. I., Knop, F. K., Holst, J. J., and Vilsboll, T. (2011). Glucagon antagonism as a potential therapeutic target in type 2 diabetes. Diabetes Obes. Metab. 13, 965-971.
8. Barwell, J., Gingell, J. J., Watkins, H. A., Archbold, J. K., Poyner, D. R., and Hay, D. L. (2011). Calcitonin and cal-citonin receptor-like receptors: common themes with family B GPCRs? Br. J. Pharmacol. 166, 51-65.
9. Bockaert, J., and Pin, J. P. (1999). Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18, 1723-1729.
10. Campbell, R. M., Bongers, J., and Felix, A.M. (1995). Rational design, syn thesis, and biological evaluation of novel growth hormone releasing factor analogues. Biopolymers 37, 67-88.
11. Chabre, M., Deterre, P., and Antonny, B (2009). The apparent cooperativ-ity of some GPCRs does not nec essarily imply dimerization. Trends Pharmacol. Sci. 30, 182-187.
12. Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Labur-the, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., and Sexton, P. M. (2003). Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278, 3293-3297.
13. Comps-Agrar, L., Kniazeff, J., Norskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prezeau, L., Bettler, B., Durroux, T., Trinquet, E., and Pin, J. P. (2011). The oligomeric state sets GABA(B) receptor signalling efficacy. EMBO J. 30, 2336-2349.
14. D'Alessio, D. (2011). The role of dys-regulated glucagon secretion in type 2 diabetes. Diabetes Obes. Metab. 13(Suppl. 1), 126-132.
15. De, A., Loening, A. M., and Gamb-hir, S. S. (2007). An improved bioluminescence resonance energy transfer strategy for imaging intra-cellular events in single cells and living subjects. Cancer Res. 67, 7175-7183.
16. De Meyts, P. (1976). Cooperative properties of hormone receptors in cell membranes. J. Supramol. Struct. 4, 241-258.
17. De Meyts, P. (2008). The insulin receptor: a prototype for dimeric, allosteric membrane receptors? Trends Biochem. Sci. 33, 376-384.
18. De Meyts, P., Roth, J., Neville, D. M. Jr., Gavin, J. R. III, and Lesniak, M. A. (1973). Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 55, 154-161.
19. de Paula, F. J., and Rosen, C. J. (2010). Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling. Horm. Metab. Res. 42, 299-306.
20. Deacon, C. F. (2007). Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes Obes. Metab. 9(Suppl. 1), 23-31.
21. Ding, W. Q., Cheng, Z. J., McEl-hiney, J., Kuntz, S. M., and Miller, L. J. (2002). Silencing of secretin receptor function by dimeriza-tion with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res. 62, 5223-5229.
22. Dong, M., Gao, F., Pinon, D. I., and Miller, L. J. (2008a). Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors. Mol. Endocrinol. 22, 1489-1499.
23. Dong, M., Pinon, D. I., and Miller, L. J. (2008b). Exploration of the endogenous agonist mechanism for activation of secretin and VPAC1 receptors using synthetic glycosy-lated peptides. J. Mol. Neurosci. 36, 254-259.
24. Dong, M., Pinon, D. I., Asmann, Y. W., and Miller, L. J. (2006). Possibleendogenous agonist mechanism for the activation of secretin family G protein-coupled receptors. Mol. Pharmacol. 70, 206-213.
25. El-Asmar, L., Springael, J. Y., Ballet, S., Andrieu, E. U., Vassart, G., and Parmentier, M. (2005). Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol. Pharmacol. 67, 460-469.
26. Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., and Schioth, H. B. (2003). The G-protein-coupled receptors in the human genome form five main families. Phyloge-netic analysis, paralogon groups,and fingerprints. Mol. Pharmacol. 63, 1256-1272.
27. Galvez, T., Duthey, B., Kniazeff, J., Blahos, J., Rovelli, G., Bettler, B., Prezeau, L., and Pin, J. P. (2001). Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J. 20, 2152-2159.
28. Gao, F., Harikumar, K. G., Dong, M., Lam, P. C. H., Sexton, P. M., Christopoulos, A., Bordner, A., Abagyan, R., and Miller, L. J. (2009). Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor. Mol. Pharmacol. 76, 264-274.
29. George, S. R., O'Dowd, B. F., and Lee, S. P. (2002). G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 1, 808-820.
30. Gomes, I., Ijzerman, A. P., Ye, K., Mail-let, E. L., and Devi, L. A. (2011). G protein-coupled receptor het-eromerization: a role in allosteric modulation of ligand binding. Mol. Pharmacol. 79, 1044-1052.
31. Gonzalez-Rey, E., Chorny, A., Fernandez-Martin, A., Varela, N., and Delgado, M. (2005). Vasoac-tive intestinal peptide family as a therapeutic target for Parkinson's disease. Expert Opin. Ther. Targets 9, 923-929.
32. GPCR-OKB. (2012). The G-protein Coupled Receptor-Oligomerization Knowledge Base Project. Available at: http://data.gpcr-okb.org/gpcr-okb/ (2012/3/4)
33. Grace, C. R., Perrin, M. H., DiGruc-cio, M. R., Miller, C. L., Rivier, J. E., Vale, W. W., and Riek, R. (2004). NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 101, 12836-12841.
34. Gregory, K. J., Sexton, P. M., and Christopoulos, A. (2010). Overviewof receptor allosterism. Curr. Protoc. Pharmacol. Chapter 1, Unit 1.21.
35. Hamdan, F. F., Percherancier, Y., Breton, B., and Bouvier, M. (2006). Monitoring protein-protein interactions in living cells by biolumi-nescence resonance energy transfer (BRET). Curr. Protoc. Neurosci. Chapter 5, Unit.
36. Hansen, J. L., Hansen, J. T., Speer-schneider, T., Lyngs, C., Erikstrup, N., Burstein, E. S., Weiner, D. M., Walther, T., Makita, N., Iiri, T., Merten, N., Kostenis, E., and Sheikh, S. P. (2009). Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer? J. Biol. Chem. 284, 1831-1839.
37. Harikumar, K. G., Ball, A. M., Sexton, P. M., and Miller, L. J. (2010). Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization. Regul. Pept. 164, 113-119.
38. Harikumar, K. G., Happs, R. M., and Miller, L. J. (2008a). Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor. Biochim. Biophys. Acta 1778, 2555-2563.
39. Harikumar, K. G., Morfis, M. M., Sexton, P. M., and Miller, L. J. (2008b). Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor. J. Mol. Neurosci. 36, 279-285.
40. Harikumar, K. G., Morfis, M. M., Lisenbee, C. S., Sexton, P. M., and Miller, L. J. (2006). Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors. Mol. Pharmacol. 69, 363-373.
41. Harikumar, K. G., Pinon, D. I., and Miller, L. J. (2007). Transmem-brane segment IV contributes a functionally important interface for oligomerization of the class II G protein-coupled secretin receptor. J. Biol. Chem. 282, 30363-30372.
42. Harmar, A. J. (2001). Family-B G-protein-coupled receptors. Genome Biol. 2, reviews3013.
43. Hebert, T. E., Moffett, S., Morello, J. P., Loisel, T. P., Bichet, D. G., Barret, C., and Bouvier, M. (1996). A pep-tide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Boil. Chem. 271, 16384-16392.
44. Heroux, M., Breton, B., Hogue, M., and Bouvier, M. (2007). Assembly and Signaling of CRLR and RAMP1 complexes assessed by BRET. Biochemistry 46, 7022-7033.
45. Hoare, S. R. (2005). Mechanisms of pep-tide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov. Today 10, 417-427.
46. Hoare, S. R., and Usdin, T. B. (2001). Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors. Curr. Pharm. Des. 7, 689-713.
47. Holst, J. J., Christensen, M., Lund, A., de, H. J., Svendsen, B., Kielgast, U., and Knop, F. K. (2011). Regulation of glucagon secretion by incretins. Diabetes Obes. Metab. 13(SUPPL. 1), 89-94.
48. Holst, J. J., Vilsboll, T., and Deacon, C. F. (2009). The incretin system and its role in type 2 diabetes mellitus. Mol. Cell. Endocrinol. 297, 127-136.
49. Hornby, P. J., and Moore, B. A. (2011). The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease. Expert Opin. Ther. Targets 15, 637-646.
50. Ishihara, T., Nakamura, S., Kaziro, Y., Takahashi, T., Takahashi, K., and Nagata, S. (1991). Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J. 10, 1635-1641.
51. Jordan, B. A., and Devi, L. A. (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700.
52. Kaczor, A. A., and Selent, J. (2011). Oligomerization of G protein-coupled receptors: biochemical and biophysical methods. Curr. Med. Chem. 18, 4606-4634.
53. Kenakin, T., and Miller, L. J. (2010). Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 62, 265-304.
54. Knop, F. K., Vilsboll, T., and Holst, J. J. (2009). Incretin-based therapy of type 2 diabetes mellitus. Curr. Protein Pept. Sci. 10, 46-55.
55. Kolakowski, L. F. Jr. (1994). GCRDb: a G-protein-coupled receptor database. Recept. Channels 2, 1-7.
56. Koshland, J. (1996). The structural basis of negative cooperativity: receptors and enzymes. Curr. Opin. Struct. Biol. 6, 757-761.
57. Kraetke, O., Wiesner, B., Eichhorst, J., Furkert, J., Bienert, M., and Beyer-mann, M. (2005). Dimerization ofcorticotropin-releasing factor receptor type 1 is not coupled to ligand binding. J. Recept. Signal Transduct. Res. 25, 251-276.
58. Kristiansen, K. (2004). Molecular mechanisms of ligand binding, signaling, and regulation within the superfam-ily of G-protein-coupled receptors: molecular modeling and mutagene-sis approaches to receptor structure and function. Pharmacol. Ther. 103, 21-80.
59. Kunishima, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Jingami, H., and Morikawa, K. (2000). Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407, 971-977.
60. Langer, I., Gaspard, N., and Robberecht, P. (2006). Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2). Br. J. Pharmacol. 148, 1051-1059.
61. Limbird, L. E., and Lefkowitz, R. J. (1976). Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes. J. Biol. Chem. 251, 5007-5014.
62. Limbird, L. E., Meyts, P. D., and Lefkowitz, R. J. (1975). Beta-adrenergic receptors: evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 64, 1160-1168.
63. Lisenbee, C. S., and Miller, L. J. (2006). Secretin receptor oligomers form intracellularly during maturation through receptor core domains. Biochemistry 45, 8216-8226.
64. Maurel, D., Comps-Agrar, L., Brock, C., Rives, M. L., Bourrier, E., Ayoub, M. A., Bazin, H., Tinel, N., Durroux, T., Prezeau, L., Trinquet, E., and Pin, J. P. (2008). Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat. Methods 5, 561-567.
65. McElvaine, A. T., and Mayo, K. E. (2006). A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology 147, 1884-1894.
66. Milligan, G. (2001). Oligomerisation of G-protein-coupled receptors. J. Cell. Sci. 114, 1265-1271.
67. Milligan, G., and Bouvier, M. (2005). Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J. 272, 2914-2925.
68. Orgaard, A. (2011). Binding and Dimer-ization Studies on the GlucagonReceptor. University of Copenhagen, Copenhagen.
69. Pal, K., Swaminathan, K., Xu, H. E., and Pioszak, A. A. (2010). Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor. J. Biol. Chem. 285, 40351-40361.
70. Parthier, C., Kleinschmidt, M., Neumann, P., Rudolph, R., Manhart, S., Schlenzig, D., Fanghanel, J., Rah-feld, J. U., Demuth, H. U., and Stubbs, M. T. (2007). Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 104, 13942-13947.
71. Pfleger,K.D.G.,andEidne,K.A. (2006). Illuminating insights into protein-protein interactions using biolumi-nescence resonance energy transfer (BRET). Nat. Methods 3, 165-169.
72. Pioszak, A. A., Harikumar, K. G., Parker, N. R., Miller, L. J., and Xu, H. E. (2010). Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation. J. Biol. Chem. 285, 12435-12444.
73. Pioszak, A. A., Parker, N. R., Gardella, T. J., and Xu, H. E. (2009). Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J. Biol. Chem. 284, 28382-28391.
74. Pioszak, A. A., Parker, N. R., Suino-Powell, K., and Xu, H. E. (2008). Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1. J. Biol. Chem. 283, 32900-32912.
75. Pioszak, A. A., and Xu, H. E. (2008). Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc. Natl. Acad. Sci. U.S.A. 105, 5034-5039.
76. Roed, S. N. (2011). Receptor Dimeriza-tion and Binding Profile of the Incretin Glucagon-Like Peptide-1. University of Copenhagen, Copenhagen.
77. Runge, S., Thogersen, H., Madsen, K., Lau, J., and Rudolph, R. (2008). Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J. Biol. Chem. 283, 11340-11347.
78. Schelshorn, D. W., Joly, F., Mutel, S., Hampe, C., Breton, B., Mutel,V., and Lutjens, R. (2011). Lateral alloster-ism in the glucagon receptor family: GLP-1 induces GPCR heteromer formation. Mol. Pharmacol. 81, 309- 318.
79. Seck, T., Baron, R., and Horne, W. C. (2003). The alternatively spliced deltae13 transcript of the rabbitcalcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression. J. Biol. Chem. 278, 23085-23093.
80. See, H. B., Seeber, R. M., Kocan, M., Eidne, K. A., and Pfleger, K. D. (2011). Application of G protein-coupled receptor-heteromer identification technology to monitor & beta;-arrestin recruitment to G protein-coupled receptor het-eromers. Assay Drug Dev. Technol. 9, 21-30.
81. Smith, N. J., and Milligan, G. (2010). Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol. Rev. 62, 701-725.
82. Springael, J. Y., Le Minh, P. N., Urizar, E., Costagliola, S., Vassart, G., and Parmentier, M. (2006). Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Mol. Pharmacol. 69, 1652-1661.
83. Stengel, A., and Tache, Y. (2010). Corticotropin-releasing factor signaling and visceral response to stress. Exp. Biol. Med. (Maywood) 235, 1168-1178.
84. Svendsen, A. M., Vrecl, M., Ellis, T. M., Heding, A., Kristensen, J. B., Wade, J. D., Bathgate, R. A., De Meyts, P., and Nohr, J. (2008a). Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family pep-tide receptor 2. Endocrinology 149, 1113-1120.
85. Svendsen, A. M., Zalesko, A., Konig, J., Vrecl, M., Heding, A., Kristensen, J. B., Wade, J. D., Bathgate, R. A. D., De Meyts, P., and Nohr, J. (2008b). Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1. Mol. Cell. Endocrinol. 296, 10-17.
86. Tan, Y. V., Couvineau, A., Murail, S., Ceraudo, E., Neumann, J. M., Lacapere, J. J., and Laburthe, M. (2006). Peptide agonist docking in the N-terminal ectodomain of a class II G protein-coupled receptor, the VPAC1 receptor. Photoaffinity, NMR, and molecular modeling. J. Biol. Chem. 281, 12792-12798.
87. ter Haar, E., Koth, C. M., bdul-Manan, N., Swenson, L., Coll, J. T., Lippke, J. A., Lepre, C. A., Garcia-Guzman, M., and Moore, J. M. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18, 1083-1093.
88. Terrillon, S., and Bouvier, M. (2004). Roles of G-protein-coupled receptor dimerization. EMBO Rep. 5, 30-34.
89. Ulrich, C. D., Holtmann, M., and Miller, L. J. (1998). Secretin and vasoactiveintestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 114, 382-397.
90. Urizar, E., Montanelli, L., Loy, T., Bonomi, M., Swillens, S., Gales, C., Bouvier, M., Smits, G., Vas-sart, G., and Costagliola, S. (2005). Glycoprotein hormone receptors: link between receptor homodimer-ization and negative cooperativity. EMBO J. 24, 1954-1964.
91. Valdez, G. R. (2009). CRF receptors as a potential target in the development of novel pharmacotherapies for depression. Curr. Pharm. Des. 15, 1587-1594.
92. Verhaar, H. J., and Lems, W. F. (2010). PTH analogues and osteoporotic fractures. Expert Opin. Biol. Ther. 10, 1387-1394.
93. Vidi, P. A., Ejendal, K. F., Przybyla, J. A., and Watts, V. J. (2011). Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling. Mol. Cell. Endocrinol. 331, 185-193.
94. Vohra, S., Chintapalli, S. V., Illingworth, C. J., Reeves, P. J., Mullineaux, P. M., Clark, H. S., Dean, M. K., Upton, G. J., and Reynolds, C. A. (2007). Computational studies of family A and family B GPCRs. Biochem. Soc. Trans. 35, 749-754.
95. Vrecl, M., Drinovec, L., Elling, C., and Heding, A. (2006). Opsin oligomer-ization in a heterologous cell system. J. Recept. Signal Transduct. Res. 26, 505-526.
96. WHO. (2011). World Healthcare Organization. Available at: http://www.who.int/en/(2012/3/4)
97. Whorton, M. R., Bokoch, M. P., Ras-mussen, S. G., Huang, B., Zare, R. N., Kobilka, B., and Sunahara, R. K. (2007). A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. U.S.A. 104, 7682-7687.
98. Young, S., Griffante, C., and Aguilera, G. (2007). Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell. Mol. Neurobiol. 27, 439-461.